comprehensive -WSS

comprehensive

author：entertainment 2025-09-28 00:47:54 - browse：273

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： Laying a path for careers in science

knowledge

WSS

Are embryos people? Reproductive medicine's future depends on the answer

Neuroscience renaissance leads to new crop of psychiatric drugs

FDA approves Leqembi, a milestone in Alzheimer’s treatment

With fresh data, a dynamic duo powers Eli Lilly to new heights

Using force crossed my mind when examining a defiant young patient

Cholera vaccine supplies dangerously low, outbreaks surging

Wikipedia

comprehensive

Wikipedia

Psychedelics group wrestles with new pharma identity

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

What does generative AI mean for health care? We asked experts

The PBM ad wars are taking over Washington, D.C.

Medicare details structure of new drug price negotiation program

Childhood vaccination ad campaign launches in the U.K.

The cancer drug shortage isn’t new — and neither are the solutions

How redistricting in 6 states could affect who controls Congress

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Are embryos people? Reproductive medicine's future depends on the answer

knowledge

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Drinking water from half of US faucets contains PFAS: Study

Pfizer is about to make a big push in cancer. Will investors listen?

'Vaccine

Neutralizing antibodies against HIV shows promise in children

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

entertainment

hotspot

knowledge

entertainment